Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary

Project Information

EPIPHARM

Grant agreement ID: 727264

DOI 10.3030/727264

Project closed

EC signature date 10 October 2016

Start date 1 February 2017

End date 31 July 2018

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 149 345,00

EU contribution € 149 345,00

Coordinated by

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE
Spain

Publications

Peer reviewed articles (3)

Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

Author(s): Sebastián Moran, Anna Martinez-Cardús, Stergios Boussios, Manel Esteller
Published in: Nature Reviews Clinical Oncology, Issue 14/11, 2017, Page(s) 682-694, ISSN 1759-4774
Publisher: Nature Publishing Group
DOI: 10.1038/nrclinonc.2017.97

Circular RNA CpG island hypermethylation-associated silencing in human cancer

Author(s): Humberto J. Ferreira, Veronica Davalos, Manuel Castro de Moura, Marta Soler, Montserrat Perez-Salvia, Alberto Bueno-Costa, Fernando Setien, Sebastian Moran, Alberto Villanueva, Manel Esteller
Published in: Oncotarget, Issue 9/49, 2018, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.25673

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

Author(s): Michäel Duruisseaux, Anna Martínez-Cardús, Maria E Calleja-Cervantes, Sebastian Moran, Manuel Castro de Moura, Veronica Davalos, David Piñeyro, Montse Sanchez-Cespedes, Nicolas Girard, Marie Brevet, Etienne Giroux-Leprieur, Coraline Dumenil, Monica Pradotto, Paolo Bironzo, Enrica Capelletto, Silvia Novello, Alexis Cortot, Marie-Christine Copin, Niki Karachaliou, Maria Gonzalez-Cao, Sergio Pera
Published in: The Lancet Respiratory Medicine, Issue 6/10, 2018, Page(s) 771-781, ISSN 2213-2600
Publisher: Elsevier Limited
DOI: 10.1016/S2213-2600(18)30284-4